Mymetics Company Description

Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland.

The company’s product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, and malaria.

Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; and national institutes of health.

The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001.

Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

Mymetics Corporation

Country	United States
Founded	1990
Industry	Biotechnology
Sector	Healthcare
Employees	2

Contact Details

Address: ROUTE DE LA CORNICHE 4 Epalinges, Delaware 1066 Switzerland
Phone	41 21 566 5772
Website	mymetics.com

Stock Details

Ticker Symbol	MYMX
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	US62856A1025
SIC Code	2836

Key Executives

Name	Position
Ronald Kempers	Chief Executive Officer, Chief Operating Officer, President and Chief Financial Officer
Mario Amacker Ph.D.	Head of Quality and Manufacturing